Subscribe to The Daily Advance RSS Feed Mobile Access E-Newsletter Log In or Register as a New User 
Classifieds
Automotive
Real Estate
Employment
Merchandise
HEALTH
HealthDay | Archives

Cancer Drug Gleevec Linked to Muscle Damage

Cancer Drug Gleevec Linked to Muscle Damage

Related News from HealthDay
Heart Drug May Be a Cancer Fighter
Gene Governs Response to Leukemia Chemotherapy
Researchers Report Progress in Fight Against Fat
Health Tip: Feel Better by Looking Good
Health Care Spending in U.S. Grew at Lowest Rate in a Decade
Obesity Linked to Ovarian Cancer
Health News Archives
   

WEDNESDAY, June 18 (HealthDay News) -- French doctors have reported a possible new side effect associated with the cancer drug Gleevec (imatinib), widely used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors.

In a letter published in the June 19 issue of the New England Journal of Medicine, the doctors describe the case of a 25-year-old woman who developed severe rhabdomyolysis while taking imatinib.

Rhabdomyolysis is the breakdown of muscle fibers resulting in the release of muscle fiber contents (myoglobin) into the bloodstream. The condition can cause kidney damage.

The woman was taking imatinib (daily dose of 400 mg) in a clinical trial for the treatment of aggressive fibromatosis (desmoid tumors) that couldn't be treated with surgery. Shortly after the start of drug treatment, the woman experienced symptoms of rhabdomyolysis.

After she stopped taking imatinib, her symptoms ceased. She then agreed to take the drug again while under medical surveillance. Twenty-four hours after she received the first daily dose of 100 mg, she suffered severe symptoms. The drug treatment was halted, and her symptoms disappeared in three days.

The woman's desmoid tumors were treated with radiotherapy, and she has not experienced any recurrence of rhabdomyolysis symptoms.

"We considered our patient's rhabdomyolysis to be induced by imatinib because of the temporal relationship (the rhabdomyolysis occurred within a few days after the initiation of imatinib therapy), the recurrence of rhabdomyolysis with the reintroduction of the drug, and normalization of the creatine kinase level after discontinuation of the drug. Although there is extensive clinical experience with the safe use of imatinib, this observation suggests that the drug may cause severe rhabdomyolysis in a small proportion of patients," the doctors wrote.

Earlier this year, a case report by Greek doctors suggested that imatinib may disrupt ovarian function and impair fertility. It was published as a letter in the New England Journal of Medicine.

More information

The MedlinePlus Medical Encyclopedia has more about rhabdomyolysis.

 

Copyright © 2008 ScoutNews, LLC. All rights reserved.



HELPFUL TOOLS

Analyze Yourself

Calculate your body mass.
Analyze yourself for depression.
Rate yourself for thyroid disease.
Do you have a sinus infection?




Marshall News Messenger Top Cars
Chevrolet Silverado 2500HD,6.6L V8 16V MPFI OHV Turbo Diesel, Standard Pickup Truck...(more) 
Chevrolet Silverado 2500HD,6.0L V8 16V MPFI OHV, Standard Pickup Truck...(more) 
Chevrolet Tahoe,8 Cylinder, Special Purpose Vehicle...(more) 
Chevrolet Silverado 1500,6 Cylinder, Standard Pickup Truck...(more) 
Saab 9-7X,5.3L V8 16V MPFI OHV, Special Purpose Vehicle...(more) 
Chrysler Town & Country,3.8L V6 12V engine produces a silky-smooth 205 horsepower at 5,200 RPM with 240 pounds-feet of torque at 4,000 RPM...(more) 
Nissan Altima,4 Cylinder, Midsize Car...(more) 
GMC Yukon,5.3L V8 16V, Special Purpose Vehicle...(more) 
-View All Top Cars-
-Place an Ad-
 

Marshall News | Marshall Weather | Sports | Lifestyle | Business News | Opinions | Classifieds | Sitemap
Marshall Cars | Marshall Real Estate | Marshall Jobs

Copyright 2008 Marshall News Messenger. All rights reserved.

By using this service, you accept the terms of our visitor agreement and privacy policy.
Registered site users, you may edit your profile.